News

The committee has also given 100% vote and recommended the FDA to also approve Adcetris as a treatment for patients with relapsed or refractory systemic anaplastic large cell

HealOr is a developer of new treatments for acute and chronic wounds such as diabetic foot ulcer (DFU), psoriasis and others. Most recently, Sabolinski has worked as the

The trascation allows BPTC to introduce Angel to new customers that require the advanced cell therapy development and cGMP manufacturing services. The agreement will facilitate to expand Angel’s

Vascazen is a prescription medical food formulated to meet the dietary omega-3 deficient needs of patients with cardiovascular disease through elevating Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) to levels

The drug has been given approval for its 37.5mg, 75mg and 150mg dosage strengths. Venlafaxine ER capsules are indicated for the treatment of major depressive disorder (MDD) and

The technology provides a method – somatic transgene immunization (STI) – to deliver a nucleic acid molecule such as DNA vaccine into B cells (a cell of the

The Unifill ready-to-fill (prefilled) syringe is a primary drug container with passive safety features fully integrated within the glass barrel. Under the agreement, Unilife has licensed Unifill syringe

O2h offers synthetic chemistry, FTE-based medicinal and process chemistry including in-vitro biology services to pharmaceutical and biotechnology companies. Heptares Chemistry head Miles Congreve said O2h has been a

Austria-based Vela offers research activities to clinical phases and up to product commercialization to its customers. VELA CEO Markus Fido said their customers will benefit from this alliance